Back to top

Image: Bigstock

Inogen Inc.

Read MoreHide Full Article

Inogen’s unique direct-to-customer business model, innovative product suite and growing patient base are key growth catalysts in our view. Based on these the company raised its full-year 2015 revenue outlook and provided a strong full-year 2016 guidance. Expansion of the company’s direct-to-consumer network and an increase in the business-to-business distribution, both domestic and international, will open up multiple avenues. Meanwhile, new products like Inogen At Home along with the upcoming Inogen One G4 are expected to drive growth further. However, foreign exchange volatility, pricing pressure and unfavorable product mix are significant headwinds.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Inogen, Inc (INGN) - free report >>

Published in